On the road of scientific research, no matter how bumpy the road is, those researches that are value-oriented to enhance the common welfare of mankind, once they are grasped and utilized by people, they will definitely put those efforts into scientific research. Staff are given the highest honors. Academician Guo Yinglu, a leading figure in the field of urology in China, and Jiang Hansheng, a doctor from Shandong, are such figures. Due to their unremitting efforts in exploring prostatic hyperplasia treatment technology, they finally successfully developed a safe, effective, simple and economical treatment method. The technical strength of China's urology surgery has risen to a new level. With the arrival of an aging society, the incidence of prostatic hyperplasia, which has no effective prevention methods, is increasing year by year, greatly reducing the quality of life of elderly men suffering from this disease. Based on the current research results and technical level, the treatment of this disease can require long-term medication, open surgery, or minimally invasive surgery. However, whether it is long-term medication or surgical treatment, both will have huge costs; at the same time, when using the two treatment methods, there are various risks, and the treatment results are difficult for patients and doctors to achieve their ideals. Furthermore, if surgical treatment is adopted, expensive equipment and skilled doctors are required. In counties and townships where there is a general lack of equipment and skills, it is difficult for patients to seek medical treatment conveniently. Under the leadership of Academician Guo Yinglu, and after long-term research and exploration by Shandong Dr. Jiang Hansheng, a technology called "transurethral columnar water bladder dilation of the prostate" for the treatment of prostate hyperplasia has recently achieved new breakthroughs and has become an ideal method for the treatment of prostate hyperplasia. In the 1980s, transurethral balloon dilatation for the treatment of prostatic hyperplasia was once abandoned due to "poor long-term efficacy." While the global urology field has abandoned this technology, Dr. Jiang Hansheng has been insisting on exploring this type of treatment. His unremitting exploration of this treatment technology has led to people jokingly calling him a "madman". After conducting on-site inspections and long-term case observations on this treatment technology, Academician Guo Yinglu believed that it has the value of in-depth research. With the financial support of the China Medical and Health Development Foundation, Academician Guo Yinglu sent doctoral students to conduct a series of studies. Through a large number of Long-term follow-up of cases, animal experiments on elderly male dogs (because the prostate mechanism of dogs is similar to that of humans), and then the improvement and shaping of the catheter used in the surgery, as well as clinical practice, finally clarified the treatment of transurethral columnar bladder dilation of the prostate. The mechanism makes this treatment mature. Now, the treatment mechanism of transurethral columnar bladder dilatation of the prostate has been clarified, the catheter has been reshaped and the technology patent has been obtained, and the entire surgical procedure has been standardized, and it has been used in many hospitals in Shandong, Jiangsu, Beijing, Tianjin, Jiangxi and other places. It has been promoted in many hospitals and patients are very satisfied with the curative effect. "This technology is in line with the spirit of medical reform that focuses on the grassroots. It can benefit the general public, greatly reduce medical expenses, and is conducive to promoting the process of medical reform. Its therapeutic effect is no less than that of current open surgery and minimally invasive surgery, so it is suitable for Promote its use in hospitals at all levels." Academician Guo Yinglu introduced the significance of transurethral columnar bladder dilation of the prostate. The steps of the entire operation are very simple and can be performed in any hospital with conditions and can be performed in ordinary county hospitals. But there needs to be a change in the mindset of doctors and patients. Doctors who have mastered open surgery and minimally invasive surgery may not take this simple method seriously, because compared with open surgery and minimally invasive surgery, the threshold for mastering transurethral columnar bladder dilation of the prostate is very low. “Any doctor who can insert a urinary catheter can master this technology,” said Academician Guo Yinglu. Because of this, doctors need to recognize the mechanism of transurethral columnar bladder dilation of the prostate, so that this technology can be promoted. In fact, through long-term follow-up observation, transurethral columnar bladder dilation of the prostate has very good results. Some patients who have undergone this surgical treatment are still enjoying the convenience and benefits brought by the surgery 9 years later. Through long-term follow-up of these postoperative patients and projection observation, it was found that the treatment effect was stable, indicating that the reliability of this technology is very high. Now, with the vigorous promotion of Academician Guo Yinglu, we are cooperating with some local hospitals free of charge to promote this technology, so as to achieve the purpose of this mature new technology benefiting the public. "Look at these four big books on urological surgery technology. When talking about this technology, they said that because 'the efficacy is not good and the controversy is too great, this book will not be written.' But now we have made breakthroughs in technology. So we will add this technology in the future," said Academician Guo Yinglu, pointing to the four medical books in his office.
After some experts in Europe and the United States heard that China had achieved this technological breakthrough, they were studying how to implement robot operation. However, one fundamental difference between robotic operation and in-person operation is that there are many uncertainties in robotic operation, the risks are much higher, and the cost of treatment may be high. "With the accumulation of time and the advancement of technology, this technology will become more mature, and there is the possibility of further simplification. This requires our doctors to use the spirit of Dr. Jiang Hansheng and pioneer and innovate." Academician Guo Yinglu said with confidence and hope .